share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zaderej Karen L.

SEC ·  Aug 22 04:05
Summary by Futu AI
On August 19, 2024, Karen L. Zaderej, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a direct purchase of 12,500 shares of common stock at a price of $7.98 per share. Following this transaction, Zaderej's direct holdings in the company increased to a total of 16,500 shares. The transaction, which took place in the open market, reflects a positive investment move by Zaderej in the company's stock.
On August 19, 2024, Karen L. Zaderej, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a direct purchase of 12,500 shares of common stock at a price of $7.98 per share. Following this transaction, Zaderej's direct holdings in the company increased to a total of 16,500 shares. The transaction, which took place in the open market, reflects a positive investment move by Zaderej in the company's stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated